-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL)
Recent price shocks in biotech stocks is a good example of the risks investors may be exposed to as healthcare continues to become more complicated.
Buy Biotech’s Burst Bubble… Just Not Quite Yet
Delay purchases unless several strong days of selling drive it to its 200-day moving average.
4 Ways to Play the Boom in Biotech Stocks
Whether you love risk or hate it, there's a way to invest in red-hot biotech stocks. Here are four options for investors of all different tolerances.
Purdue’s Pill Success Is Bad News for Zogenix Zohydro, ZGNX Stock
Purdue Pharma's plans to pursue FDA approval of its back-pain medication could mean the end of a Zogenix drug, sending ZGNX stock plunging.
Is It Too Late to Buy the Rally in Small Caps?
Small cap stocks have delivered stellar returns in 2014, but the rally may be getting overextended. Is there any opportunity left for small caps?
5 Biotech Stocks Promising Future Rewards
Biotech is one of the dynamic sectors in our economy, and in the stock market as well. These 5 biotech stocks are solid buys in our Portfolio Grader model.
MYL Earnings Momentum Propels Mylan Stock to a Buy
Biogeneric drugmaker Mylan is undergoing soaring growth based on its backlog of generics waiting for U.S government approval to market. Mylan stock is a buy
5 Biotech Stocks That Are Buyout Candidates
These biotech stocks are this year's top M&A candidates. But even if they're not acquired, they're solid biopharma investments.
This Biotech Bubble Is Bound to Burst
Biotech stocks have been hot thanks to a wave of M&A speculation. That wave, however, has run its course, putting these stocks and biotech ETFs at risk.
3 Healthcare Stocks That Look Ripe to Rally
All healthcare stocks are not created equal, but these three are currently trading in promising technical patterns that signal more upside.
Trade of the Day: CVS Caremark (CVS)
Is this move worth $2 billion in PR and publicity? We think it is and it looks like most CVS stock investors agree.
Regeneron: REGN Stock Takes Out All the Stops
After already rallying for a few days, REGN stock on Tuesday shifted into a new gear and broke out to new all-time highs. What's next for Regeneron?
Trade of the Day: Stemline Therapeutics (STML)
Technicals can certainly give insight into big-name stocks–but they really shine in finding the best stocks to buy that might not have crossed your radar.
Among Biotechs, Amgen Stock Offers Dividend Income
Biotech giant AMGN has a nice benefit Amgen stock in that it pays a dividend. With a low payout ratio, investors should look for increases in the future.
Healthcare Stocks: No Longer a Sure Thing
Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels.
AMGN: Amgen Stock Future Looks Bright for Investors
Amgen released earnings that put a smile on investor's faces, and Amgen stock looks like a solid buy for the long term
MRK: Merck Stock a Strong Performer In the Pharma Space
Merck is one the most high profile companies in the pharmaceutical industry, and Merck stock is well worth a look for investors. I rate it a buy today.
BDSI Stock – New Chronic Pain Drug Sends BioDelivery Soaring
Good results from a late-stage trial for a drug from BioDelivery Sciences sent BDSI stock surging in Friday trading.
Under Obamacare, Risks Grow for High-Margin Drug Stocks
The implementation of Obamacare means that reimbursement rates for certain drugs will be cut. Here's what that means for drug stocks like Questcor.
